A pediatric patient of hemorrhagic acute transverse myelitis

Brain Dev. 2017 Mar;39(3):252-255. doi: 10.1016/j.braindev.2016.09.007. Epub 2016 Sep 26.

Abstract

An 11-year-old boy presented with progressive leg hypesthesia but no history of trauma. Dysuria and constipation appeared subsequent to gait difficulty. He was admitted 8days after onset. Spinal magnetic resonance imaging (MRI) revealed longitudinal hyperintensity with cord swelling and hypointensity on T2-weighted images, suggesting severe inflammation and microbleeding change, respectively. Gadolinium contrast-enhanced MRI demonstrated mild enhancement in the lesions. Platelet count and coagulation findings were normal, and cerebrospinal fluid analysis showed no pleocytosis. He was diagnosed with idiopathic acute transverse myelitis (ATM), and intravenous methylprednisolone pulse therapy and plasmapheresis were initiated. On day 14, motor dysfunction aggravated suddenly, accompanied by expanding hemorrhagic lesions. Thereafter, administration of intravenous immunoglobulin, repeated intravenous methylprednisolone pulse therapy and prednisolone for one month resulted in complete recovery four months later. Both anti-aquaporin-4 and anti-myelin oligodendrocyte glycoprotein antibodies were negative. We presented the first pediatric case showing hemorrhagic spinal lesions in the clinical course of ATM. This severe complication should be recognized in the management of ATM.

Keywords: Children; Myelitis; Plasmapheresis; Spinal hemorrhage; Treatment.

Publication types

  • Case Reports

MeSH terms

  • Aquaporin 4 / immunology
  • Child
  • Hemorrhage / etiology*
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use*
  • Magnetic Resonance Imaging / methods
  • Male
  • Methylprednisolone / administration & dosage
  • Methylprednisolone / therapeutic use*
  • Myelitis, Transverse / complications
  • Myelitis, Transverse / diagnosis
  • Myelitis, Transverse / drug therapy*
  • Myelitis, Transverse / pathology*
  • Prednisolone / administration & dosage
  • Prednisolone / therapeutic use*
  • Spinal Cord / pathology*
  • Treatment Outcome

Substances

  • AQP4 protein, human
  • Aquaporin 4
  • Immunoglobulins, Intravenous
  • Prednisolone
  • Methylprednisolone